Literature DB >> 19655163

Ducts isolated from the pancreas of CFTR-null mice secrete fluid.

Patricia Pascua1, Mónica García, M Paz Fernández-Salazar, M Pilar Hernández-Lorenzo, José J Calvo, William H Colledge, R Maynard Case, Martin C Steward, José I San Román.   

Abstract

The pancreatic pathology in cystic fibrosis (CF) is normally attributed to the failure of ductal fluid secretion resulting from the lack of functional CF transmembrane conductance regulator (CFTR). However, murine models of CF show little or no pancreatic pathology. To resolve this dichotomy we analysed the transport mechanisms involved in fluid and electrolyte secretion by pancreatic ducts isolated from CFTR-null mice. Experiments were performed on cultured interlobular duct segments isolated from the pancreas of the Cftr(tm1Cam) strain of CFTR-null mouse. Fluid secretion to the closed luminal space was measured by video microscopy. The secretory response of ducts isolated from CF mice to cAMP-elevating agonists forskolin and secretin was significantly reduced compared with wild type but not abolished. The Cl(-)- and HCO(3) (-) -dependent components of the ductal secretion were affected equally by the absence of CFTR. The secretory response to carbachol stimulation was unaltered in CF ducts. Loading the ductal cells with the Ca2+ chelator BAPTA completely abolished carbachol-evoked secretion, but did not affect forskolin-evoked secretion in CF or wild-type ducts. We conclude that pancreatic duct cells from CF mice can secrete a significant amount of water and electrolytes by a cAMP-stimulated mechanism that is independent of CFTR and cannot be ascribed to the activation of calcium-activated chloride channels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655163     DOI: 10.1007/s00424-009-0704-9

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  26 in total

1.  The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3.

Authors:  Meeyoung Park; Shigeru B H Ko; Joo Young Choi; Gaia Muallem; Philip J Thomas; Alexander Pushkin; Myeong-Sok Lee; Joo Young Kim; Min Goo Lee; Shmuel Muallem; Ira Kurtz
Journal:  J Biol Chem       Date:  2002-10-25       Impact factor: 5.157

2.  A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice.

Authors:  S D Freedman; M H Katz; E M Parker; M Laposata; M Y Urman; J G Alvarez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Mapping of five new putative anion transporter genes in human and characterization of SLC26A6, a candidate gene for pancreatic anion exchanger.

Authors:  H Lohi; M Kujala; E Kerkelä; U Saarialho-Kere; M Kestilä; J Kere
Journal:  Genomics       Date:  2000-11-15       Impact factor: 5.736

4.  cAMP inhibition of murine intestinal Na/H exchange requires CFTR-mediated cell shrinkage of villus epithelium.

Authors:  Lara R Gawenis; Craig L Franklin; Janet E Simpson; Bradley A Palmer; Nancy M Walker; Tarra M Wiggins; Lane L Clarke
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

5.  Calcium-activated chloride conductance is not increased in pancreatic duct cells of CF mice.

Authors:  J P Winpenny; B Verdon; H L McAlroy; W H Colledge; R Ratcliff; M J Evans; M A Gray; B E Argent
Journal:  Pflugers Arch       Date:  1995-05       Impact factor: 3.657

6.  cAMP-regulated whole cell chloride currents in pancreatic duct cells.

Authors:  M A Gray; S Plant; B E Argent
Journal:  Am J Physiol       Date:  1993-03

7.  Basolateral anion transport mechanisms underlying fluid secretion by mouse, rat and guinea-pig pancreatic ducts.

Authors:  M Paz Fernández-Salazar; Patricia Pascua; José Julián Calvo; María A López; R Maynard Case; Martin C Steward; José I San Román
Journal:  J Physiol       Date:  2004-02-20       Impact factor: 5.182

8.  Cystic fibrosis in the mouse by targeted insertional mutagenesis.

Authors:  J R Dorin; P Dickinson; E W Alton; S N Smith; D M Geddes; B J Stevenson; W L Kimber; S Fleming; A R Clarke; M L Hooper
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

9.  Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis.

Authors:  Jeffrey S Clark; David H Vandorpe; Marina N Chernova; John F Heneghan; Andrew K Stewart; Seth L Alper
Journal:  J Physiol       Date:  2008-01-03       Impact factor: 5.182

10.  A mouse model for the delta F508 allele of cystic fibrosis.

Authors:  B G Zeiher; E Eichwald; J Zabner; J J Smith; A P Puga; P B McCray; M R Capecchi; M J Welsh; K R Thomas
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  11 in total

Review 1.  The physiological roles of secretin and its receptor.

Authors:  Syeda Afroze; Fanyin Meng; Kendal Jensen; Kelly McDaniel; Kinan Rahal; Paolo Onori; Eugenio Gaudio; Gianfranco Alpini; Shannon S Glaser
Journal:  Ann Transl Med       Date:  2013-10

2.  Deletion of Slc26a6 alters the stoichiometry of apical Cl-/HCO-3 exchange in mouse pancreatic duct.

Authors:  Ying Song; Akiko Yamamoto; Martin C Steward; Shigeru B H Ko; Andrew K Stewart; Manoocher Soleimani; Bai-Chun Liu; Takaharu Kondo; Chun-Xiang Jin; Hiroshi Ishiguro
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-15       Impact factor: 4.249

Review 3.  New animal models of cystic fibrosis: what are they teaching us?

Authors:  Nicholas W Keiser; John F Engelhardt
Journal:  Curr Opin Pulm Med       Date:  2011-11       Impact factor: 3.155

Review 4.  Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.

Authors:  Alicia K Olivier; Katherine N Gibson-Corley; David K Meyerholz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

Review 5.  Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.

Authors:  Ziying Yan; Zoe A Stewart; Patrick L Sinn; John C Olsen; Jim Hu; Paul B McCray; John F Engelhardt
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-12       Impact factor: 5.032

Review 6.  The cystic fibrosis of exocrine pancreas.

Authors:  Michael Wilschanski; Ivana Novak
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 7.  Acid-base transport in pancreas-new challenges.

Authors:  Ivana Novak; Kristian A Haanes; Jing Wang
Journal:  Front Physiol       Date:  2013-12-20       Impact factor: 4.566

8.  Novel Insight Into the Role of CFTR in Lacrimal Gland Duct Function in Mice.

Authors:  Orsolya Berczeli; Eszter Vizvári; Máté Katona; Dénes Török; László Szalay; Ferenc Rárosi; István Németh; Zoltán Rakonczay; Péter Hegyi; Chuanqing Ding; Edit Tóth-Molnár
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

9.  Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction.

Authors:  Rebecca Darrah; Ilya Bederman; Megan Vitko; Dana M Valerio; Mitchell L Drumm; Craig A Hodges
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

10.  The Importance of Aquaporin 1 in Pancreatitis and Its Relation to the CFTR Cl- Channel.

Authors:  Viktória Venglovecz; Petra Pallagi; Lajos V Kemény; Anita Balázs; Zsolt Balla; Eszter Becskeházi; Eleonóra Gál; Emese Tóth; Ágnes Zvara; László G Puskás; Katalin Borka; Matthias Sendler; Markus M Lerch; Julia Mayerle; Jens-Peter Kühn; Zoltán Rakonczay; Péter Hegyi
Journal:  Front Physiol       Date:  2018-07-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.